BamSEC and AlphaSense Join Forces
Learn More

PharmaCyte Biotech Inc.

NASDAQ: PMCB    
Share price (12/20/24): $1.64    
Market cap (12/20/24): $11.4 million
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.2
from 10-K 3 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.2
from 8-K 22 pages Femasys Inc. Series B Warrant to Purchase Common Stock
12/34/56
EX-4.1
from 8-K 22 pages Femasys Inc. Series a Warrant to Purchase Common Stock
12/34/56
EX-4.1
from 8-K 24 pages PharmaCyte Biotech, Inc. Warrant to Purchase Common Stock
12/34/56
EX-4.2
from 10-K 2 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.3
from 8-K 15 pages Placement Agent Common Stock Purchase Warrant PharmaCyte Biotech, Inc
12/34/56
EX-4.2
from 8-K 15 pages Series a Warrant Common Stock Purchase Warrant PharmaCyte Biotech, Inc
12/34/56
EX-4.1
from 8-K 15 pages Pre-Funded Common Stock Purchase Warrant PharmaCyte Biotech, Inc
12/34/56
EX-4.3
from 8-K 16 pages Underwriter Common Stock Purchase Warrant PharmaCyte Biotech, Inc
12/34/56
EX-4.2
from 8-K 16 pages Pre-Funded Common Stock Purchase Warrant PharmaCyte Biotech, Inc
12/34/56
EX-4.1
from 8-K 15 pages Common Stock Purchase Warrant PharmaCyte Biotech, Inc
12/34/56
EX-4.2
from 10-K 2 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.1
from S-3 38 pages PharmaCyte Biotech, Inc. Indenture Dated as of , 20___ [ ] Trustee
12/34/56
EX-4.3
from S-3 41 pages PharmaCyte Biotech, Inc. Company and [Trustee] Trustee Indenture Dated as of [·], 20[·] Subordinated Debt Securities
12/34/56
EX-4.1
from S-3 37 pages PharmaCyte Biotech, Inc. Company and [Trustee] Trustee Indenture Dated as of [·], 20[·] Senior Debt Securities
12/34/56
EX-4.2
from 8-K 10 pages PharmaCyte Biotech, Inc. Common Stock Warrant Agreement
12/34/56
EX-4.1
from 8-K 10 pages PharmaCyte Biotech, Inc. Common Stock Warrant Agreement
12/34/56
EX-4.4
from S-3 50 pages Nuvilex, Inc. Company and [Trustee] Trustee Indenture Dated as of [·], 20[·] Subordinated Debt Securities
12/34/56
EX-4.3
from S-3 53 pages Nuvilex, Inc. Issuer and [Trustee] Trustee Indenture Dated as of [·], 20[·] Senior Debt Securities
12/34/56
EX-4.1
from 8-K 15 pages Mutual Termination and Release Agreement
12/34/56